Development and Comparison of Treatment Decision Tools for Glucocorticoid-Induced Osteoporosis
Long-term Glucocorticoid (GC) use results in compromised bone strength and fractures, and several treatment recommendations have been developed to prevent fractures, but none have been validated in a real-world setting. This study aims to create a treatment decision tool and compares this tool to th...
Main Authors: | Jia-Feng Chen, Shan-Fu Yu, Wen-Chan Chiu, Chi-Hua Ko, Chung-Yuan Hsu, Han-Ming Lai, Ying-Chou Chen, Yu-Jih Su, Hong-Yo Kang, Tien-Tsai Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/14/4/452 |
Similar Items
-
Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: 2022 update
by: Ta-Wei Tai, et al.
Published: (2023-01-01) -
Engagement in Primary Prevention Program among Rural Veterans With Osteoporosis Risk
by: Karla L. Miller, et al.
Published: (2022-10-01) -
Ten-year follow-up of fracture risk in a systematic population-based screening program: the risk-stratified osteoporosis strategy evaluation (ROSE) randomised trialResearch in context
by: Tanja Gram Petersen, et al.
Published: (2024-05-01) -
Fracture Risk in Men and Women With Vertebral Fractures Identified Opportunistically on Routine Computed Tomography Scans and Not Treated for Osteoporosis: An Observational Cohort Study
by: Michael Kriegbaum Skjødt, et al.
Published: (2023-05-01) -
Cost-effectiveness of opportunistic QCT-based osteoporosis screening for the prediction of incident vertebral fractures
by: Sebastian Rühling, et al.
Published: (2023-07-01)